Low‑dose computed tomography (LDCT) is the established screening backbone for lung cancer in high‑risk populations. However, its clinical value depends on a complete pathway, including eligibility assessment, image acquisition, nodule interpretation, follow‑up, referral, quality assurance, and harm reduction, and not o...
Hao-Jing Li, Yun-Xiang Zhu, Xiao-Ming Li· Cancer Treatment and Researc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.